LY456236 is an Orally Active mGlu1 Receptor Antagonist for Neurological Disease Research
Epilepsy is one of the most common neurological diseases in the world. Firstly, Epilepsy affects people of all ages, races, social classes, and geographical locations. Secondly, Epilepsy is a disease…